Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Senti Biosciences Holdings Inc's Business Segments
Senti Biosciences Holdings Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
1
Largest Segment
Reportable
Total Revenue
$ 0
Regions Reported
-
Revenue Share by Reportable Segment - Q2 FY2026
- Reportable100%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Reportable | $ 0 | 100% |
Description of Senti Biosciences Holdings Inc
Senti Biosciences Inc is a biotechnology company focused on developing next-generation gene circuit therapies to treat various diseases. The company's innovative approach combines synthetic biology, gene editing, and genetic engineering to engineer cells that can sense and respond to specific disease signals in the body.
Senti Biosciences aims to harness the power of gene circuits, which are complex networks of genes that can be engineered to perform precise functions within cells. By programming these gene circuits, the company can instruct cells to respond to disease-related signals, such as the presence of specific molecules or the activation of certain genes. This allows for targeted and dynamic control of cell behavior in response to disease progression, enabling more effective and personalized treatments.
One of the key technologies developed by Senti Biosciences is its proprietary synthetic gene circuits, which are designed to detect disease signals and trigger specific therapeutic actions. These gene circuits are built using advanced genetic engineering techniques and can be introduced into various cell types, including immune cells and stem cells. The company's platform technology enables the customization of gene circuits to target a wide range of diseases, including cancer, genetic disorders, and autoimmune diseases.
Senti Biosciences also leverages gene editing tools, such as CRISPR-Cas9, to modify the genetic makeup of cells and enhance their therapeutic properties. This enables precise manipulation of specific genes or genetic pathways to improve the safety and efficacy of the engineered cells.
Additionally, the company has developed sophisticated computational algorithms and machine learning capabilities to accelerate the design and optimization of gene circuits. These tools help analyze vast amounts of genomic data and predict how different gene circuit designs will behave within cells, guiding the development of more effective therapies.
The core team at Senti Biosciences comprises experts in synthetic biology, molecular biology, gene editing, and computational biology. Their combined expertise fuels the company's mission to revolutionize the field of gene circuit therapies and transform the way diseases are treated.
In summary, Senti Biosciences Inc is at the forefront of developing advanced gene circuit therapies by combining synthetic biology, gene editing, and genetic engineering techniques. Their platform technology allows for the programming of cells to sense and respond specifically to disease signals, offering the potential for more targeted and personalized treatments for various diseases.
Senti Biosciences aims to harness the power of gene circuits, which are complex networks of genes that can be engineered to perform precise functions within cells. By programming these gene circuits, the company can instruct cells to respond to disease-related signals, such as the presence of specific molecules or the activation of certain genes. This allows for targeted and dynamic control of cell behavior in response to disease progression, enabling more effective and personalized treatments.
One of the key technologies developed by Senti Biosciences is its proprietary synthetic gene circuits, which are designed to detect disease signals and trigger specific therapeutic actions. These gene circuits are built using advanced genetic engineering techniques and can be introduced into various cell types, including immune cells and stem cells. The company's platform technology enables the customization of gene circuits to target a wide range of diseases, including cancer, genetic disorders, and autoimmune diseases.
Senti Biosciences also leverages gene editing tools, such as CRISPR-Cas9, to modify the genetic makeup of cells and enhance their therapeutic properties. This enables precise manipulation of specific genes or genetic pathways to improve the safety and efficacy of the engineered cells.
Additionally, the company has developed sophisticated computational algorithms and machine learning capabilities to accelerate the design and optimization of gene circuits. These tools help analyze vast amounts of genomic data and predict how different gene circuit designs will behave within cells, guiding the development of more effective therapies.
The core team at Senti Biosciences comprises experts in synthetic biology, molecular biology, gene editing, and computational biology. Their combined expertise fuels the company's mission to revolutionize the field of gene circuit therapies and transform the way diseases are treated.
In summary, Senti Biosciences Inc is at the forefront of developing advanced gene circuit therapies by combining synthetic biology, gene editing, and genetic engineering techniques. Their platform technology allows for the programming of cells to sense and respond specifically to disease signals, offering the potential for more targeted and personalized treatments for various diseases.
Senti Biosciences Inc. is at the forefront of biotechnology innovation, specializing in programmable biology technology aimed at improving existing therapies and paving the way for new treatments. By intertwining synthetic biology, machine learning, and gene editing techniques, Senti seeks to transform precision medicine with an emphasis on effectively treating complex diseases such as cancer, genetic disorders, and autoimmune illnesses.
Segments
Senti Biosciences operates predominantly within the biotechnology sector, honing in on several key segments:
1. Gene and Cell Therapy: This segment focuses on developing therapies that modify a persons genes to treat or prevent diseases. Senti is dedicated to creating novel gene therapy solutions capable of addressing both genetic and acquired diseases.
2. Synthetic Biology: Senti is actively involved in synthetic biology, utilizing engineering principles to construct and design biological systems. This field enables the creation of new biological parts, devices, and systems that greatly enhance the capability of therapeutic interventions.
3. Precision Medicine: Through their cutting-edge technologies, Senti aims to refine the concept of precision medicine, where treatments are tailored to individual patients based on their genetic makeup and the underlying biology of their diseases.
Products
Senti Biosciences boasts an impressive range of innovative products that stem from their proprietary programmable biology platform:
1. Gene Editing Tools: Senti’s advanced platform delivers precise and effective gene editing capabilities, allowing researchers to modify genes associated with various diseases. These tools comprise genetic circuits, gene expression control modules, and specialized gene targeting systems to facilitate precise modifications.
2. Synthetic Gene Circuits: Senti provides a customizable library of synthetic gene circuits designed to be integrated into host cells. These circuits allow for the fine-tuning of gene expression, enabling users to construct complex regulatory networks that can adjust cellular functions dynamically.
3. Engineered Cells: Senti specializes in the creation of engineered cells tailored for therapeutic purposes. These cells are designed to deliver specific treatments, express therapeutic proteins, and release bioactive molecules with precision, thus enhancing their efficacy in targeting and eliminating diseased cells, particularly in oncology.
4. Modular Cell Designs: Within engineered cells, Senti also develops modular designs that allow for a mix-and-match approach to create custom cell therapies based on patients unique requirements.
Services
In addition to their robust product offerings, Senti Biosciences provides a suite of services to facilitate the implementation and advancement of their technologies:
1. Customized Platform Integration: Senti collaborates extensively with partners, such as academic institutions and pharmaceutical companies, to help integrate their programmable biology technology within existing research and development frameworks. This integration ensures that their innovative solutions meet specific operational needs and therapeutic goals.
2. Therapeutic Development Assistance: They offer comprehensive support in therapeutic development by aiding partners in evaluating and optimizing treatment candidates. This includes guidance on preclinical study design, structuring clinical trials, and navigating regulatory pathways to achieve approval for new therapies.
3. Research Collaborations: Senti actively fosters research collaborations to enhance the understanding and application of their technologies. By partnering with other research entities, they promote knowledge exchange, innovation, and the continuous advancement of the biotechnology field.
4. Consultative Services: To complement their technologies and products, Senti provides consultative services where their experts offer insights on the best practices for utilizing programmable biology innovations in various research settings.
Conclusion
Overall, Senti Biosciences Inc. is committed to revolutionizing the landscape of therapy development by leveraging their advanced programmable biology platform. Their extensive product suite and offering of collaborative services equip partners with the necessary tools and expertise to undertake groundbreaking research and develop pioneering treatments, ultimately aiming to provide innovative solutions to a diverse range of illnesses. Through their commitment to precision medicine and engineered biological solutions, Senti is poised to make significant contributions to the future of healthcare and therapeutic interventions.
Segments
Senti Biosciences operates predominantly within the biotechnology sector, honing in on several key segments:
1. Gene and Cell Therapy: This segment focuses on developing therapies that modify a persons genes to treat or prevent diseases. Senti is dedicated to creating novel gene therapy solutions capable of addressing both genetic and acquired diseases.
2. Synthetic Biology: Senti is actively involved in synthetic biology, utilizing engineering principles to construct and design biological systems. This field enables the creation of new biological parts, devices, and systems that greatly enhance the capability of therapeutic interventions.
3. Precision Medicine: Through their cutting-edge technologies, Senti aims to refine the concept of precision medicine, where treatments are tailored to individual patients based on their genetic makeup and the underlying biology of their diseases.
Products
Senti Biosciences boasts an impressive range of innovative products that stem from their proprietary programmable biology platform:
1. Gene Editing Tools: Senti’s advanced platform delivers precise and effective gene editing capabilities, allowing researchers to modify genes associated with various diseases. These tools comprise genetic circuits, gene expression control modules, and specialized gene targeting systems to facilitate precise modifications.
2. Synthetic Gene Circuits: Senti provides a customizable library of synthetic gene circuits designed to be integrated into host cells. These circuits allow for the fine-tuning of gene expression, enabling users to construct complex regulatory networks that can adjust cellular functions dynamically.
3. Engineered Cells: Senti specializes in the creation of engineered cells tailored for therapeutic purposes. These cells are designed to deliver specific treatments, express therapeutic proteins, and release bioactive molecules with precision, thus enhancing their efficacy in targeting and eliminating diseased cells, particularly in oncology.
4. Modular Cell Designs: Within engineered cells, Senti also develops modular designs that allow for a mix-and-match approach to create custom cell therapies based on patients unique requirements.
Services
In addition to their robust product offerings, Senti Biosciences provides a suite of services to facilitate the implementation and advancement of their technologies:
1. Customized Platform Integration: Senti collaborates extensively with partners, such as academic institutions and pharmaceutical companies, to help integrate their programmable biology technology within existing research and development frameworks. This integration ensures that their innovative solutions meet specific operational needs and therapeutic goals.
2. Therapeutic Development Assistance: They offer comprehensive support in therapeutic development by aiding partners in evaluating and optimizing treatment candidates. This includes guidance on preclinical study design, structuring clinical trials, and navigating regulatory pathways to achieve approval for new therapies.
3. Research Collaborations: Senti actively fosters research collaborations to enhance the understanding and application of their technologies. By partnering with other research entities, they promote knowledge exchange, innovation, and the continuous advancement of the biotechnology field.
4. Consultative Services: To complement their technologies and products, Senti provides consultative services where their experts offer insights on the best practices for utilizing programmable biology innovations in various research settings.
Conclusion
Overall, Senti Biosciences Inc. is committed to revolutionizing the landscape of therapy development by leveraging their advanced programmable biology platform. Their extensive product suite and offering of collaborative services equip partners with the necessary tools and expertise to undertake groundbreaking research and develop pioneering treatments, ultimately aiming to provide innovative solutions to a diverse range of illnesses. Through their commitment to precision medicine and engineered biological solutions, Senti is poised to make significant contributions to the future of healthcare and therapeutic interventions.